Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement under Regulations 18(7) of The Securities and Exchange Board ....

Open offer triggeredListed-company acquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹63.90

prior close

₹64.89

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+0.2% vs market

Pharmaceuticals peers, median of 149sector-2.0%+0.6% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4-1.6+0.2-2.0+0.6

Next day

+1.2-1.1+2.3-1.5+2.7

-2.2-1.4-0.8-1.9-0.3

-0.6-2.5+1.8-3.8+3.1

+0.2-2.8+3.0-3.1+3.3

-1.1-3.6+2.5-4.1+3.0

+0.0-3.4+3.4-3.4+3.4

15d

-2.3-1.4-0.9-3.8+1.5

-4.7-2.7-2.0-4.1-0.6

-7.0-3.1-4.0-5.0-2.0

-21.8+0.4-22.2-4.1-17.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Saffron Capital Advisors, acting as manager to the open offer, has submitted the Offer Opening Public Announcement to BSE for Pharmaids Pharmaceuticals Ltd. The acquirer Shankarappa Nagaraja Vinaya Babu, along with Person Acting in Concert Tumkur Trade Center Pvt Ltd, is offering to buy up to 91,69,632 equity shares (face value Rs 10 each) at Rs 62.15 per share, aggregating to approximately Rs 56.99 crore. The offer is being made under SEBI (SAST) Regulations, 2011. The announcement was published on August 1, 2025 in Financial Express (English), Jansatta (Hindi), Udaykala (Kannada, Bangalore edition), and Navshakti (Marathi, Mumbai edition).

Likely market impact

Public shareholders of Pharmaids Pharmaceuticals can tender their shares at Rs 62.15 each during the open offer window, providing an exit opportunity at a defined price. This signals a change in control or significant stake acquisition, which may influence the stock's trading price around the offer period.